相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
303162-79-0
- 规格:
10 mM * 1 mL/5 mg/10 mg/50 mg/100 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥1023.0 |
|---|---|---|---|
| 规格: | 5 mg | 产品价格: | ¥930.0 |
| 规格: | 10 mg | 产品价格: | ¥1200.0 |
| 规格: | 50 mg | 产品价格: | ¥3700.0 |
| 规格: | 100 mg | 产品价格: | ¥5920.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
TAK-715
CAS No. : 303162-79-0
MCE 国际站:TAK-715
产品活性:TAK-715 是一种具有口服活性,有效的 p38 MAPK 抑制剂,对 p38α 和 p38β 的 IC50 分别为 7.1 nM,200 nM。TAK-715 抑制酪蛋白激酶 I (CK1δ/ε),从而调节 Wnt/β-catenin 信号传导的激活。TAK-715 在大鼠关节炎模型中显示出良好的作用。
研究领域:MAPK/ERK Pathway | Stem Cell/Wnt | Cell Cycle/DNA Damage
作用靶点:p38 MAPK | Casein Kinase
In Vitro: TAK-715 (compound 8h) inhibits LPS-stimulated release of TNF-α from THP-1 (IC50=48 nM) and has no inhibitory activity for major CYPs, including CYP3A4. TAK-715 has no inhibition to p38γ/δ, JNK1, ERK1, IKKβ, MEKK1 or TAK1 (IC50>10 μM of all).
TAK 715 (10 μM; 1 hour) inhibits Wnt-3a-induced hDvl2 phosphorylation and the hDvl2 shift in U2OS-EFC cells.
TAK-715 (1 μM; pretreatment for 16 hours) dramatically suppresses Norepinephrine (NE)-stimulated induction of fibronectin, CTGF, and Snai1 expression in TGF-β1-treated HK-2 cells at both the mRNA and protein levels.
In Vivo: TAK-715 (compound 8h; 3-30 mg/kg; PO) significantly reduces the secondary paw volume.
TAK-715 (10 mg/kg; PO) has a Cmax of 0.19 μg/mL and an AUC of 1.16 μg h/mL.
相关产品:Drug Repurposing Compound Library Plus | Clinical Compound Library Plus | Bioactive Compound Library Plus | Cell Cycle/DNA Damage Compound Library | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | Stem Cell Signaling Compound Library | Wnt/Hedgehog/Notch Compound Library | Clinical Compound Library | Anti-Aging Compound Library | Drug Repurposing Compound Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Anti-COVID-19 Compound Library | Pyroptosis Compound Library | Orally Active Compound Library | Anti-Lung Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Neurodegenerative Disease-related Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Rare Diseases Drug Library | Antidepressant Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Cancer Stem Cells Compound Library | Heterocyclic Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Highly Selective Inhibitors Library | Serine/Threonine Kinase Inhibitor Library | LY294002 | Adezmapimod | SB 202190 | Afatinib | Doramapimod | Silmitasertib | IWP-2 | Aspirin | Oxidopamine hydrobromide | BI-3406 | Emodin | Ellagic acid | Butyzamide | Hesperetin | Muramyl dipeptide | C16-PAF | Ralimetinib dimesylate | D4476 | PD 169316 | Umbralisib | Dehydrocorydaline | LXH254 | PF-670462 dihydrochloride | Neflamapimod | Diprovocim | Losmapimod | PF-3644022 | TBB
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
技术资料暂无技术资料 索取技术资料

















